Moderna, Inc. (NASDAQ:MRNA)

PRESS RELEASE

published on 02/14/2025 at 12:28, 11 months 15 days ago

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed

Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF

published on 01/29/2025 at 13:05, 1 year ago

Moderna to Announce Financial Results for Q4 and 2024

Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE

published on 01/29/2025 at 13:00, 1 year ago

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website

Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF

published on 01/24/2025 at 12:35, 1 year ago

Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply

COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE

published on 01/24/2025 at 12:30, 1 year ago

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options

COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF

published on 01/17/2025 at 22:33, 1 year ago

Moderna Advances mRNA-Based Influenza Vaccine Development

Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE

published on 01/17/2025 at 22:28, 1 year ago

Moderna Announces Updates on Pandemic Influenza Program
Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium

Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF

published on 01/13/2025 at 13:05, 1 year ago

Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference

Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE

published on 01/13/2025 at 13:00, 1 year ago

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines

Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF

published on 11/25/2024 at 13:05, 1 year 2 months ago

Moderna to Present at December 2024 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna

Published on 01/31/2026 at 03:15, 1 day 9 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 10 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 10 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 12 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 13 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 20 hours 37 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 9 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 14 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 16 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 17:45, 1 day 18 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 2 days 4 hours ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 2 days 18 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 2 days 18 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 2 days 18 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News